Acta Scientific Cancer Biology

Research Article Volume 4 Issue 1

Using Prostatic Fluid Levels of Zinc to Strontium Concentration Ratio in Non-Invasive and Highly Accurate Screening for Prostate Cancer

Vladimir Zaichick1* and Sofia Zaichick2

1Radionuclide Diagnostics Department, Medical Radiological Research Centre, Obninsk, Russia

2Laboratory of Dr. Gabriela Caraveo Piso, Feinberg School of Medicine, Northwestern University, Chicago, Il USA

*Corresponding Author: Vladimir Zaichick, Radionuclide Diagnostics Department, Medical Radiological Research Centre, Obninsk, Russia.

Received: November 18, 2019; Published: December 06, 2019

×

Abstract

  Prostate specific antigen (PSA) does not provide the high reliability and precision that is required for an accurate screening for prostate cancer (PCa). The aim of our study was to search for a simple, rapid, direct, preferably non-invasive, and highly accurate biomarker and procedure for the screening for PCa. For this purpose the levels of strontium (Sr) and zinc (Zn) were prospectively evaluated in expressed prostatic fluid (EPF). Also Zn/Sr concentration ratio was calculated for EPF samples, obtained from 38 apparently healthy males and from 33, 51, and 24 patients with chronic prostatitis (CP), benign prostatic hyperplasia (BPH) and PCa, respectively. Measurements were performed using an application of energy dispersive X-ray fluorescent (EDXRF) microanalysis developed by us. It was found that in the EPF of cancerous prostates the levels of Zn and Zn/Sr were significantly lower in comparison with those in the EPF of normal, inflamed, and hyperplastic prostates. It was shown that “Sensitivity”, “Specificity” and “Accuracy” of PCa identification using the Zn and Zn/Sr levels in the EPF samples were all significantly higher than those resulting from of PSA tests in blood serum. It was concluded that the Zn and Zn/Sr levels in EPF, obtained by EDXRF, is a fast, reliable, and non-invasive diagnostic tool that can be successfully used by local, non-urologist physicians at the point-of-care to provide a highly effective PCa screening and as an additional confirmatory test before a prostate gland biopsy.

KeywordsUrology Screening; Prostate Cancer; Benign Prostatic Hyperplasia; Chronic Prostatitis; Expressed Prostatic Fluid; Trace Element Content; Trace Element Concentration Ratio; Energy-Dispersive X-Ray Fluorescent Analysis

×

References

  1. Taitt HE. “Global trends and prostate cancer: A review of incidence, detection, and mortality as influenced by race, ethnicity, and geographic location”. American Journal of Men’s Health6 (2018):1807-1823.
  2. Dasgupta P., et al. “Geographical Variations in Prostate Cancer Outcomes: A Systematic Review of International Evidence”. Frontiers in Oncology 9 (2019):238.
  3. Siegel RL., et al. “Cancer Statistics”. CA: A Cancer Journal for Clinicians1 (2017):7-30.
  4. Qi D., et al. “Trends of prostate cancer incidence and mortality in Shanghai, China from 1973 to 2009”. Prostate 75 (2015):1662-1668.
  5. Tkac J., et al. “Prostate-specific antigen glycoprofiling as diagnostic and prognostic biomarker of prostate cancer”. Interface Focus2 (2019):20180077.
  6. Zapała P., et al. “What can be expected from prostate cancer biomarkers. A clinical perspective”. Urologia Internationalis1 (2018):1-12.
  7. Sorokin I and Mian BM. “Risk calculators and updated tools to select and plan a repeat biopsy for prostate cancer detection”. Asian Journal of Andrology6 (2015):864-869.
  8. Qu M., et al. “Current early diagnostic biomarkers of prostate cancer”. Asian Journal of Andrology4 (2014):549-554.
  9. Thompson IM., et al. “Prevalence of prostate cancer among men with a prostate-specific antigen level < or=4.0 ng per milliliter”. The New England Journal of Medicine 350 (2004):2239-2246.
  10. Alotaibi KM. “Incidence of prostate cancer among patients with prostate-related urinary symptoms: A single institution series in 10 years”. Urology Annals2 (2019):135-138.
  11. Hayes B., et al. “Developments in point-of-care diagnostic technology for cancer detection”. Diagnostics (Basel)2 (2018): 39.
  12. Zaichick V. “INAA and EDXRF applications in the age dynamics assessment of Zn content and distribution in the normal human prostate”. Journal of Radioanalytical and Nuclear Chemistry 262 (2004):229-234.
  13. Zaichick V and Zaichick S. “The effect of age on Br, Ca, Cl, K, Mg, Mn, and Na mass fraction in pediatric and young adult prostate glands investigated by neutron activation analysis”. Applied Radiation and Isotopes 82 (2013):145-151.
  14. Zaichick V and Zaichick S. “INAA application in the assessment of Ag, Co, Cr, Fe, Hg, Rb, Sb, Sc, Se, and Zn mass fraction in pediatric and young adult prostate glands”. Journal of Radioanalytical and Nuclear Chemistry 298 (2013):1559-1566.
  15. Zaichick V and Zaichick S. “NAA-SLR and ICP-AES Application in the assessment of mass fraction of 19 chemical elements in pediatric and young adult prostate glands”. Biological Trace Element Research 156 (2013):357-366.
  16. Zaichick V and Zaichick S. “Use of neutron activation analysis and inductively coupled plasma mass spectrometry for the determination of trace elements in pediatric and young adult prostate”. American Journal of Analytical Chemistry 4 (2013):696-706.
  17. Zaichick V and Zaichick S. “Relations of bromine, iron, rubidium, strontium, and zinc content to morphometric parameters in pediatric and nonhyperplastic young adult prostate glands”. Biological Trace Element Research 157 (2014):195-204.
  18. Zaichick V and Zaichick S. “Relations of the neutron activation analysis data to morphometric parameters in pediatric and nonhyperplastic young adult prostate glands”. Advances in Biomedical Science and Engineering1 (2014):26-42.
  19. Zaichick V and Zaichick S. “Relations of the Al, B, Ba, Br, Ca, Cl, Cu, Fe, K, Li, Mg, Mn, Na, P, S, Si, Sr, and Zn mass fractions to morphometric parameters in pediatric and nonhyperplastic young adult prostate glands”. Bio Metals 27 (2014):333-348.
  20. Zaichick V and Zaichick S. “The distribution of 54 trace elements including zinc in pediatric and nonhyperplastic young adult prostate gland tissues”. Journal of Clinical and Laboratory Investigation Updates1 (2014):1-15.
  21. Zaichick V and Zaichick S. “Androgen-dependent chemical elements of prostate gland”. Andrology and Gynecology: Current Research 2 (2014): 2.
  22. Zaichick V and Zaichick S. “Differences and relationships between morphometric parameters and zinc content in nonhyperplastic and hyperplastic prostate glands”. British Journal of Medicine and Medical Research8 (2015):692-706.
  23. Zaichick V. “The prostatic urethra as a Venturi effect urine-jet pump to drain prostatic fluid”. Medical Hypotheses 83 (2014): 65-68.
  24. Mackenzie AR., et al. “Zinc content of expressed human prostate fluid”. Nature (London)4810 (1962):72-73.
  25. Marmar JL., et al. “Values for zinc in whole semen, fraction of split ejaculate and expressed prostatic fluid”. Urology5 (1980):478-480.
  26. Zaichick V., et al. “Method for diagnostics of prostate diseases”. Certificate of Invention (1981).
  27. Zaichick V., et al. “Zinc concentration in human prostatic fluid: normal, chronic prostatitis, adenoma, and cancer”. International Urology and Nephrology5 (1996):687-694.
  28. Zaichick V., et al. “Method and portable facility for measurement of trace element concentration in prostate fluid samples using radionuclide-induced energy-dispersive X-ray fluorescent analysis”. Nuclear Science and Technology6 (2016):1-8.
  29. Zaichick V and Zaichick S. “Effect of age on the Br, Fe, Rb, Sr, and Zn concentrations in human prostatic fluid investigated by energy-dispersive X-ray fluorescent microanalysis”. Micro Medicine2 (2018):94-104.
  30. Zaichick V and Zaichick S. “Trace element concentrations in the expressed prostatic secretion of normal and hyperplastic prostate”. Journal of Urology and Nephrology Studies3 (2018):1-7.
  31. Zaichick V and Zaichick S. “Trace elements of expressed prostatic secretions as a source for biomarkers of prostatic cancer”. Journal of Clinical Research in Oncology1 (2018):1-7.
  32. Zaichick V and Zaichick S. “Br, Fe, Rb, Sr, and Zn levels in the prostatic secretion of patients with chronic prostatitis”. International Archives of Urology and Complications 4 (2018): 046.
  33. Zaichick V and Zaichick S. “Significance of trace element quantities in the prostatic secretion of patients with chronic prostatitis and prostate cancer”. Journal of Biomedical Research and Reviews1 (2019): 56-61.
  34. Zaichick V and Zaichick S. “Ratio of zinc to bromine, iron, rubidium, and strontium concentration in the prostatic fluid of patients with benign prostatic hyperplasia”. Acta Scientific Medical Sciences6 (2019):49-56.
  35. Zaichick V and Zaichick S. “Ratio of zinc to bromine, iron, rubidium, and strontium concentration in expressed prostatic secretions as a source for biomarkers of prostatic cancer”. American Journal of Research 5-6 (2019):140-150.
  36. Zaichick V and Zaichick S. “Some trace element contents and ratios in prostatic fluids as ancillary diagnostic tools in distinguishing between the benign prostatic hyperplasia and chronic prostatitis”. Archives of Urology1 (2019):12-20.
  37. Zaichick V and Zaichick S. “Ratio of zinc to bromine, iron, rubidium, and strontium concentration in the prostatic fluid of patients with chronic prostatitis”. Global Journal of Medical Research: F Diseases4 (2019):9-15.
  38. Zaichick V and Zaichick S. “Significance of trace element quantities in the prostatic secretion of patients with benign prostatic hyperplasia and prostate cancer”. Journal of Cancer Metastasis and Treatment48 (2019):1-9.
  39. Zaichick V and Zaichick S. “Some trace element contents and ratios in prostatic fluids as ancillary diagnostic tools in distinguishing between the chronic prostatitis and prostate cancer”. Medical Research and Clinical Case Reports1 (2019):1-10.
  40. Zaichick V. “Applications of synthetic reference materials in the Medical Radiological Research Centre”. Fresenius Journal of Analytical Chemistry 352 (1995):219-223.
  41. Hjertholm P., et al. “Variation in general practice prostate-specific antigen testing and prostate cancer outcomes: An ecological study”. International Journal of Cancer 136 (2015): 435-442.
  42. Genes VS. “Simple methods for cybernetic data treatment of diagnostic and physiological studies”. Nauka, Moscow (1967).
  43. Rossmann M., et al. “Determination of key chemical elements by energy dispersive X-Ray fluorescence analysis in commercially available infant and toddler formulas consumed in UK”. Nutrition and Food Technology: Open Access4 (2016):1-7.
×

Citation

Citation: Vladimir Zaichick and Sofia Zaichick. "Using Prostatic Fluid Levels of Zinc to Strontium Concentration Ratio in Non-Invasive and Highly Accurate Screening for Prostate Cancer".Acta Scientific Cancer Biology 4.1 (2020): 12-21.



Member In



News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 15, 2020.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US